Sign Out
Use in Pregnancy: In animal studies, Erythropoietin alfa has been shown to decrease foetal body weight, delay assification and increase foetal mortality when given in weekly doses of approximately 20 times the recommended human weekly dose. These changes are interpreted as being secondary to decreased maternal body weight gain.
There no adequate and well controlled studies in pregnant women.
Use in Lactation: Erythropoietin is present in human milk. However, it is not known whether Erythropoietin alfa is distributed into human milk, Erythropoietin alfa should be used with caution in nursing woman.
